TW238246B - Pharmaceutical composition for reducing the renal toxicity and enhancing the effect of antitumor - Google Patents

Pharmaceutical composition for reducing the renal toxicity and enhancing the effect of antitumor

Info

Publication number
TW238246B
TW238246B TW082108799A TW82108799A TW238246B TW 238246 B TW238246 B TW 238246B TW 082108799 A TW082108799 A TW 082108799A TW 82108799 A TW82108799 A TW 82108799A TW 238246 B TW238246 B TW 238246B
Authority
TW
Taiwan
Prior art keywords
reducing
pharmaceutical composition
antitumor
enhancing
effect
Prior art date
Application number
TW082108799A
Other languages
Chinese (zh)
Inventor
Kawabata Hironori
Moriguchi Koei
Endo Takeshi
Original Assignee
Fuji Chem Ind Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fuji Chem Ind Co Ltd filed Critical Fuji Chem Ind Co Ltd
Application granted granted Critical
Publication of TW238246B publication Critical patent/TW238246B/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A pharmaceutical composition for reducing the renal toxicity due to the platinum mixture in organic body is composed of the effective composition of SAMe and its sulfate, and shaping agent and/or aid drug.
TW082108799A 1993-09-03 1993-10-22 Pharmaceutical composition for reducing the renal toxicity and enhancing the effect of antitumor TW238246B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP125093 1993-09-03

Publications (1)

Publication Number Publication Date
TW238246B true TW238246B (en) 1995-01-11

Family

ID=51483955

Family Applications (1)

Application Number Title Priority Date Filing Date
TW082108799A TW238246B (en) 1993-09-03 1993-10-22 Pharmaceutical composition for reducing the renal toxicity and enhancing the effect of antitumor

Country Status (1)

Country Link
TW (1) TW238246B (en)

Similar Documents

Publication Publication Date Title
HRP930239A2 (en) Anti-inflamatory 4-aminophenol derivatives
AU578428B2 (en) Trace-labeled conjugates of metallothionein and target- seeking biologically active molecules
ID28003A (en) ADAMANTANA'S DEMONS
YU51095A (en) BENZOKAZOLYL - AND BENZOTIAZOLYL-OXAZO LIDINONES
FI950169L (en) Analogues of PTH and PTHRP, their synthesis and use in the treatment of osteoporosis
NZ335146A (en) N-(N'-substituted glycyl)-2-cyanopyrrolidine derivatives and medicaments
AP9801169A0 (en) N-hydroxy-B-sulfonyl propionamide derivatives.
UA41879C2 (en) Drug for treating diseases affecting motoneurons
EP0209689A3 (en) Use of tetrahydrobiopterins in the treatment of infantile autism
AU6414994A (en) Composition and method for reducing toxicity of biologically-active factors
NZ337246A (en) Pharmaceutical composition comprising amoxycillin and clavulanate
BG102250A (en) The use of marigold-extracted glycosides for the treatment of psoriasis
EP1294375A4 (en) Method of treatment of seborrheic dermatitis
KR900007424A (en) Method of using N-acetylglucosamine as a cytoprotective agent and composition thereof
PT78628B (en) Pharmaceutical composition with reduced toxicity
ZA963784B (en) Terpenoidic derivatives useful as antitumor agents.
TW238246B (en) Pharmaceutical composition for reducing the renal toxicity and enhancing the effect of antitumor
MY108692A (en) Topical composition
ES8607217A1 (en) Improvements in or relating to anticonvulsant agents.
EP0831869A4 (en) Diphosphonate derivatives of therapeutic agents
GB2306885B (en) Supersaturated Pharmaceutical Compositions
IL109108A0 (en) Salts of (s)-alpha- phenyl - 2 - pyridineethanamine, their preparation and pharmaceutical compositions containing them
HU900525D0 (en) Process for the production of medical preparations for treating endotoxinemy
ZA947401B (en) Use of partially methylated beta-cyclodextrins as absorption promoters in the preparation of pharmaceutical compositions for the transcutaneous administration of active principles
TW333453B (en) Pharmaceutical composition comprising toremifene for use in the treatment of autoimmune diseases